Conteltinib
Product Specifications
CAS Number
1384860-29-0
Target
FAK, PYK2, ALK
Related Pathways
Angiogenesis, Cytoskeletal Signaling, Tyrosine Kinase/Adaptors
Purity
0.9954
Bioactivity
Conteltinib (CT-707) is an enzyme inhibitor with antitumor activity targeting FAK, ALK, and Pyk2.Conteltinib exhibits significant inhibition of FAK, overcomes hypoxia-mediated sorafenib resistance in hepatocellular carcinoma through inhibition of YAP signaling, and can be used in advanced ALK-positive non-small-cell lung cancer and lymphoma.
Smiles
COc1cc(ccc1Nc1nc2NCCc2c(Nc2ccccc2S(=O)(=O)NC(C)C)n1)N1CCC(CC1)N1CCN(C)CC1
Molecular Formula
C32H45N9O3S
Molecular Weight
635.82
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
040291-ML490 100 µL
POU5F2, ID (POU5F2, SPRM1, POU domain, class 5, transcription factor 2, Sperm 1 POU domain transcription factor) (MaxLight 490) discontinued
Sign In for Pricing
View Details 
orb3009624-01 20 µg
Recombinant Human Probable non-functional T cell receptor beta variable 17 (TVB17)
Sign In for Pricing
View Details orb3009624-02 100 µg
Recombinant Human Probable non-functional T cell receptor beta variable 17 (TVB17)
Sign In for Pricing
View Details